Download information sheet on this study (Microsoft Office .docx format)
For many women, the discovery of a suspicious breast abnormality and obtaining further diagnostic testing can be a source of worry and uncertainty.
What is the study about?
Our study will evaluate the feasibility to provide telephone support prior to and after your visit to the GRDC. The purpose of the study is to test if the provision of a telephone support by a healthcare professional prior to your visit to the GRDC helps to prepare for the day’s event, and to see if receiving telephone support reduces uncertainty and worries.
Who is eligible to participate?
- Women who have been referred to the GRDC following the discovery of a suspicious breast abnormality
What is expected with your participation in this study?
Your participation involves taking part in a telephone call that would take place prior to your schedule day of testing. The telephone call will take approximately 15 minutes which includes answering questions on your emotional level along with providing you guidance on how to prepare for your diagnostic screening appointment. Following the day of testing, you will be asked to complete a new set of questions. Then, three days following your day of testing, you will receive a second telephone call. Finally, three weeks following you day of testing, you be asked to complete the same set of questions on your emotional level and to review your understanding of the day’s event. These questionnaires can be completed over the telephone with the research coordinator or online, on a secured website.
If you have agreed to participate, please use the following links to complete the set of questions.
Questions:
- Prior to your days of testing
- Following your day of testing (you attended the GRDC)
- Three weeks following your day of testing
More information
If you would like more information, please contact the Study Coordinator:
Lorena Baku 416-581-8631
ELLICSR – Health, Wellness, & Cancer Survivorship Centre
Dr. Christine Maheu, Principal Investigator, Clinical Scientist ELLICSR, University Health Network
